500 likes | 508 Views
This report provides an overview of the activities and outcomes of hematopoietic cell transplantation in Japan. It includes data on recipient demographics, donor types, stem cell sources, recipient age, main diseases, and survival rates.
E N D
Title: Activities and Outcomes of Hematopoietic Cell Transplantation in Japan
Annual Number of Transplant Recipients in Japan by Transplant Type 3 The Japanese Data Center for Hematopoietic Cell Transplantation
Transplant Recipients in Japan, by Donor Type and Stem Cell Sources(Autologous) The Japanese Data Center for Hematopoietic Cell Transplantation
Transplant Recipients in Japan, by Donor Type and Stem Cell Sources(Allogeneic) The Japanese Data Center for Hematopoietic Cell Transplantation
Annual Trends in Transplants by Recipient Age at Transplant (Autologous / Allogeneic) 6 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends in Transplants by Stem Cell Sources and Recipient Age at Transplant 7 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends in Transplants for Leukemia and Malignant Lymphoma by Recipient Age at Transplant 8 The Japanese Data Center for Hematopoietic Cell Transplantation
Indications for Hematopoietic Stem Cell Transplants in 1991-2017 (Age≤15) 9 The Japanese Data Center for Hematopoietic Cell Transplantation
Indications for Hematopoietic Stem Cell Transplants in 1991-2017(Age≥16) 10 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends of Main Diseasefor Autologous Transplants in 1991-2017 (Age≤15) 11 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends of Main Disease for Allogeneic Transplants in 1991-2017 (Age≤15) 12 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends of Main Diseasefor Autologous Transplants in 1991-2017(Age≥16) 13 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends of Main Disease for Allogeneic Transplants in 1991-2017 (Age≥16) 14 The Japanese Data Center for Hematopoietic Cell Transplantation
Stem Cell Sources for Autologous Transplants by Year 15 The Japanese Data Center for Hematopoietic Cell Transplantation
Stem Cell Sources for Allogeneic Transplants by Year 16 The Japanese Data Center for Hematopoietic Cell Transplantation
Stem Cell Sources for Unrelated Donor Transplants by Year 17 The Japanese Data Center for Hematopoietic Cell Transplantation
Allogeneic Transplants for Age ≤15yearsby Donor Type and Graft Source 18 The Japanese Data Center for Hematopoietic Cell Transplantation
Allogeneic Transplants for Age 16-50 yearsby Donor Type and Graft Source 19 The Japanese Data Center for Hematopoietic Cell Transplantation
Allogeneic Transplants for Age ≥51yearsby Donor Type and Graft Source 20 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends in Transplants by Disease Status (Risk) at Transplant( AML / ALL / CML / MDS ) 21 The Japanese Data Center for Hematopoietic Cell Transplantation
Trends in Allogeneic Transplants by Conditioning Regimen 22 The Japanese Data Center for Hematopoietic Cell Transplantation
Annual Number of Allogeneic HCTs from related donorsby Year and Donor Type(HLA-matched/HLA-non-id relative ) 23 The Japanese Data Center for Hematopoietic Cell Transplantation
100-day Survival by Year of Transplants,Donor, and Age (Autologous / Allogeneic) The Japanese Data Center for Hematopoietic Cell Transplantation
One-year Survival by Year of Transplants,Donor,and Age(Autologous / Allogeneic) The Japanese Data Center for Hematopoietic Cell Transplantation
100-day Survival by Year of AllogeneicTransplants,Donor, and Stem Cell Sources (Age<50) The Japanese Data Center for Hematopoietic Cell Transplantation
One-year Survival by Year of Allogeneic Transplants,Donor, and Stem Cell Sources (Age<50) The Japanese Data Center for Hematopoietic Cell Transplantation
100-day Survival by Year of Allogeneic Transplants,Donor, and Stem Cell Sources (Age≥50) The Japanese Data Center for Hematopoietic Cell Transplantation
One-year Survival by Year of Allogeneic Transplants,Donor, and Stem Cell Sources (Age≥50) The Japanese Data Center for Hematopoietic Cell Transplantation
100-day Survival by Year of Transplants,Disease Status, and Age( AML / ALL / CML / MDS ) The Japanese Data Center for Hematopoietic Cell Transplantation
One-year Survival by Year of Transplants,Disease Status, and Age( AML / ALL / CML /MDS ) The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Transplants, by Donor Type and Stem Cell Sources (1991-2017) 32 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Transplants for Leukemia, 1991-2017 33 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Transplants for Malignant Lymphoma and MM/PCD, 1991-2017 34 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Autologous Transplants for Acute Leukemia by Recipient Age, 1991-2017 35 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Autologous Transplants for Malignant Lymphoma by Recipient Age, 1991-2017 36 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Autologous Transplants for MM/PCD, Age≥16 Years, 1991-2017 37 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplants for AML, Age≤15 Years, 1991-2017 38 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor AML, Age≥16 Years, 1991-2017 39 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor ALL, Age≤15 Years, 1991-2017 40 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor ALL, Age≥16 Years, 1991-2017 41 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor CML, Age≤15 Years, 1991-2017 42 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor CML, Age≥16 Years, 1991-2017 43 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor MDS, Age≤15 Years, 1991-2017 44 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor MDS, Age≥16 Years, 1991-2017 45 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor NHL, Age≤15 Years, 1991-2017 46 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor NHL, Age≥16 Years, 1991-2017 47 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor MM/PCD, Age≥16 Years, 1991-2017 48 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor AA, Age≤15 Years, 1991-2017 49 The Japanese Data Center for Hematopoietic Cell Transplantation
Survival after Allogeneic Transplantsfor AA, Age≥16 Years, 1991-2017 50 The Japanese Data Center for Hematopoietic Cell Transplantation